1. Home
  2. SFBC vs FATE Comparison

SFBC vs FATE Comparison

Compare SFBC & FATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SFBC
  • FATE
  • Stock Information
  • Founded
  • SFBC 1953
  • FATE 2007
  • Country
  • SFBC United States
  • FATE United States
  • Employees
  • SFBC N/A
  • FATE N/A
  • Industry
  • SFBC Savings Institutions
  • FATE Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • SFBC Finance
  • FATE Health Care
  • Exchange
  • SFBC Nasdaq
  • FATE Nasdaq
  • Market Cap
  • SFBC 127.6M
  • FATE 152.4M
  • IPO Year
  • SFBC N/A
  • FATE 2013
  • Fundamental
  • Price
  • SFBC $50.40
  • FATE $1.04
  • Analyst Decision
  • SFBC
  • FATE Hold
  • Analyst Count
  • SFBC 0
  • FATE 8
  • Target Price
  • SFBC N/A
  • FATE $5.43
  • AVG Volume (30 Days)
  • SFBC 4.0K
  • FATE 2.1M
  • Earning Date
  • SFBC 04-29-2025
  • FATE 05-20-2025
  • Dividend Yield
  • SFBC 1.51%
  • FATE N/A
  • EPS Growth
  • SFBC N/A
  • FATE N/A
  • EPS
  • SFBC 1.95
  • FATE N/A
  • Revenue
  • SFBC $36,560,000.00
  • FATE $13,631,000.00
  • Revenue This Year
  • SFBC N/A
  • FATE N/A
  • Revenue Next Year
  • SFBC N/A
  • FATE N/A
  • P/E Ratio
  • SFBC $25.86
  • FATE N/A
  • Revenue Growth
  • SFBC N/A
  • FATE N/A
  • 52 Week Low
  • SFBC $39.25
  • FATE $0.66
  • 52 Week High
  • SFBC $55.99
  • FATE $5.92
  • Technical
  • Relative Strength Index (RSI)
  • SFBC 47.40
  • FATE 46.67
  • Support Level
  • SFBC $50.26
  • FATE $0.91
  • Resistance Level
  • SFBC $51.33
  • FATE $1.34
  • Average True Range (ATR)
  • SFBC 0.49
  • FATE 0.13
  • MACD
  • SFBC -0.03
  • FATE -0.03
  • Stochastic Oscillator
  • SFBC 22.82
  • FATE 22.41

About SFBC Sound Financial Bancorp Inc.

Sound Financial Bancorp Inc operates as the holding company for Sound Community Bank that provides traditional banking and other financial services for individuals and businesses. It attracts retail and commercial deposits from the public and invests those funds, along with borrowed funds, in loans secured by first and second mortgages on one-to-four-family residences including home equity loans and lines of credit, commercial and multifamily real estate, construction and land, consumer and commercial business loans. The bank also offers secured and unsecured consumer loan products, including manufactured home loans, floating home loans, automobile loans, boat loans, and recreational vehicle loans.

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

Share on Social Networks: